| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/24/2004 | US20040122021 High optical purity of both levoratatory and dextrorotatory forms; simple, economic synthesis |
| 06/24/2004 | US20040122020 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity |
| 06/24/2004 | US20040122011 such as 3-[3-[N-isopropyl-N-(4-methoxyphenyl-sulfonyl)amino]-phenyl]-3-(3-pyridyl)-2(E)-propenohydroxamic acid; for treatment/prevention of neoplasia/inflammation; kits |
| 06/24/2004 | US20040122006 such as 7-[(2-aminophenyl)sulfanyl]-2H-1,4-benzoxazin-3(4H)-one; oxidation/reduction; deblocking/deprotectiing; cardiovascular disorders |
| 06/24/2004 | US20040122004 such as (1R,2R)-N-[(1S)-2-amino-1-(4-fluorophenyl)-2-oxoethyl]-2-(4-{[{[ethyl(2-hydroxyethyl)amino]carbonyl}(4-fluorophenyl)amino]methyl}phenyl)cyclohexanecarboxamide; for prevention/treatment of cardiovascular disorders |
| 06/24/2004 | US20040122002 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof |
| 06/24/2004 | US20040121996 Benzoxazin-3-ones and derivatives thereof as therapeutic agents |
| 06/24/2004 | US20040121981 Administering therapeutically effective amount of a compound which binds to a galectin |
| 06/24/2004 | US20040121979 Pharmaceutically active uridine esters |
| 06/24/2004 | US20040121976 Anti-inflammatory vectors |
| 06/24/2004 | US20040121956 For therapy of diseases in animals and for the control of insects that are injurious or harmful to plants or animals |
| 06/24/2004 | US20040121940 Anticancer prodrugs, enhance enzymatic activation rates |
| 06/24/2004 | US20040121376 Antisense modulation of interleukin-5 signal transduction |
| 06/24/2004 | US20040121372 Comprises receptors for advanced glycation endproduct polypeptides for use in diagnosis and treatment inflammation, infection, sepsis, autoimmune, atherosclerotic and nervous system disorders |
| 06/24/2004 | US20040121345 Identification of a human n-terminal acetyltransferase gene |
| 06/24/2004 | US20040121030 Extract from the pods of lupin seeds containing lupeol |
| 06/24/2004 | US20040121028 Plant based agents as bioavailability / bioefficacy enhancers for drugs and nutraceuticals |
| 06/24/2004 | US20040121012 Sustained release matrix for high-dose insoluble drugs |
| 06/24/2004 | US20040121004 protecting the gastrointestinal tract from non-steroidal antiinflammatory drug therapy by administering a NSAID in combination with a buffer and a proton pump inhibitor in a single non-enterically coated dosage form |
| 06/24/2004 | US20040120957 Use of A33 antigens JAM-it |
| 06/24/2004 | US20040120945 Cell surface molecule mediating cell adhesion and signal transmission |
| 06/24/2004 | DE69233189T2 Heteroarylpiperidine-pyrrolidine und piperazine und ihre anwendung als antipsychotisches und analgetisches mittel Heteroarylpiperidines-pyrrolidine and piperazine and its application as an antipsychotic and analgesic medium |
| 06/24/2004 | CA2508601A1 Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k |
| 06/23/2004 | EP1431391A2 Rantes mutants and therapeutic applications thereof |
| 06/23/2004 | EP1431310A1 RECOMBINANT ANTI−OSTEOPONTIN ANTIBODY AND USE THEREOF |
| 06/23/2004 | EP1431293A1 Water-soluble phenylpyridazine derivatives and drugs containing the same |
| 06/23/2004 | EP1431290A1 Novel nitrogenous compound and use thereof |
| 06/23/2004 | EP1431285A1 Reverse hydroxamic acid derivatives |
| 06/23/2004 | EP1431284A1 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
| 06/23/2004 | EP1431275A1 Diaryl ether derivative, addition salt thereof, and immunosuppressant |
| 06/23/2004 | EP1430894A1 Lymphocytic activation inhibitor and remedial agent for autoimmune disease |
| 06/23/2004 | EP1430304A1 Method and agent for diagnosing and treating chronic inflammatory bowel diseases |
| 06/23/2004 | EP1430302A2 Inhibitors of glycosaminoglycans |
| 06/23/2004 | EP1430144A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 06/23/2004 | EP1430133A2 A soluble toll-like receptor |
| 06/23/2004 | EP1430132A2 Methods of using 33751, a human potassium channel family member |
| 06/23/2004 | EP1430130A2 Nucleic acid-associated proteins |
| 06/23/2004 | EP1430126A1 Dna sequences for human angiogenesis genes |
| 06/23/2004 | EP1430120A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 06/23/2004 | EP1430053A1 Chemical compounds |
| 06/23/2004 | EP1430050A1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity |
| 06/23/2004 | EP1430048A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 06/23/2004 | EP1430046A1 Process for preparing pyridyl-alkylsulfonyl pyrazole derivatives |
| 06/23/2004 | EP1430042A2 Bicyclic heterocycles as rxr ligands |
| 06/23/2004 | EP1430041A2 Novel sulfonic acid derivatives |
| 06/23/2004 | EP1430030A1 N-type calcium channel antagonists for the treatment of pain |
| 06/23/2004 | EP1430029A1 N-type calcium channel antagonists for the treatment of pain |
| 06/23/2004 | EP1430020A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 06/23/2004 | EP1429915A1 Systems, methods and apparatuses for manufacturing dosage forms |
| 06/23/2004 | EP1429914A1 Systems, method and apparatuses for manufacturing dosage forms |
| 06/23/2004 | EP1429807A2 Combination of a nsaid and a pde-4 inhibitor |
| 06/23/2004 | EP1429806A2 Extracellular massengers |
| 06/23/2004 | EP1429795A1 Method for producing extracts of pelargonium sidoides and/or pelargonium reniforme, and the use of said extracts |
| 06/23/2004 | EP1429784A2 High throughput screening assays using fatty acid synthetic enzymes |
| 06/23/2004 | EP1429782A1 Modulation of vitamin storage |
| 06/23/2004 | EP1429779A2 Androstanes as androgen receptor modulators |
| 06/23/2004 | EP1429774A2 Stent coated with a substained-release drug delivery |
| 06/23/2004 | EP1429773A1 Process for making substituted pyrazoles |
| 06/23/2004 | EP1429772A1 N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl)pyrazole |
| 06/23/2004 | EP1429762A1 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
| 06/23/2004 | EP1429760A1 Novel combination |
| 06/23/2004 | EP1429736A2 Organoleptically acceptable intraorally disintegrating compositions |
| 06/23/2004 | EP1429723A1 Treating effects of excessive reactive oxygen species |
| 06/23/2004 | EP1429689A1 Rational drug therapy device and methods |
| 06/23/2004 | EP1252157B1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 06/23/2004 | EP1237851A4 SALTS OF i Cis /i -4-CYANO-4- 3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID |
| 06/23/2004 | EP1230227B1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 06/23/2004 | EP0983251B1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof |
| 06/23/2004 | EP0966424B1 Aminobenzophenones as inhibitors of interleukin and tnf |
| 06/23/2004 | EP0930886B1 Formulation for use in the prevention of pathogen induced diseases including hiv and hsv |
| 06/23/2004 | EP0779889B1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE |
| 06/23/2004 | CN1507450A Novel cyclo azaphospha hydrocarbons |
| 06/23/2004 | CN1507447A Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 06/23/2004 | CN1507444A 2,3-diazanaphthalene derivatives with angiogenesis inhibiting activity |
| 06/23/2004 | CN1507442A Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 06/23/2004 | CN1507434A Novel 4-anilinoquinoline-3-carboxamides compound |
| 06/23/2004 | CN1507429A Extract from the pods of lupin seeds containing lupeol |
| 06/23/2004 | CN1507354A Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 06/23/2004 | CN1507350A N-acetylcysteine compositions and methods for the treatment and preventino of drug toxicity |
| 06/23/2004 | CN1507349A Medicaments containing a polyamine as an active substance |
| 06/23/2004 | CN1507348A Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders |
| 06/23/2004 | CN1506355A Diphenyl benzimidazole compound containing sulfonyl group and its prepn process, medicinal composition and use |
| 06/23/2004 | CN1506116A Process for preparing degradable polymer and medical composition containing the said polymer and use thereof |
| 06/23/2004 | CN1506091A Plaster for treating rheumatic osteodynia |
| 06/23/2004 | CN1506085A Chinese goldthread soft capsule for clearing away adverse lung energy and its prepn process |
| 06/23/2004 | CN1506078A Prepn of dispersive Yinhuang tablet |
| 06/23/2004 | CN1506076A Externally appied medicine for relieving pain and diminishing inflammation |
| 06/23/2004 | CN1506045A P-ethyl phenol aminophenol anal injection for children and its prepn |
| 06/23/2004 | CN1154647C Imidazonephthyridines and their use in inducing cytokine biosynthesis |
| 06/23/2004 | CN1154635C Novel compounds with analgesic effect |
| 06/23/2004 | CN1154510C Preparation of directly mouldable tabletting auxiliary |
| 06/23/2004 | CN1154494C Adenosine A3 receptor modulators |
| 06/23/2004 | CN1154490C Celecoxib compositions |
| 06/23/2004 | CN1154489C Heterocyclic vinylethers against neurological disorders |
| 06/23/2004 | CN1154482C Particles coated with granulated crystalline ibuprofen |
| 06/23/2004 | CN1154481C Taste masked pharmaceutical compositions |
| 06/23/2004 | CN1154480C Process for making flurbiprofen lozenges |
| 06/22/2004 | US6753442 Amorphous nitric esters and their pharmaceutical compositions |
| 06/22/2004 | US6753340 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents |
| 06/22/2004 | US6753335 Delta agonists for nervous system pain |